KCNC1
Voltage-gated potassium channel KCNC1
Also known as: KCNC1_HUMAN, Kv3.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48547
- Gene
- KCNC1
- Ensembl
- ENSG00000129159
- Chromosome
- 11
- Canonical length
- 511 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Subcellular location
- Nucleoplasm,Nuclear membrane,Vesicles,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of a family of integral membrane proteins that mediate the voltage-dependent potassium ion permeability of excitable membranes. Alternative splicing is thought to result in two transcript variants encoding isoforms that differ at their C-termini. These isoforms have had conflicting names in the literature: the longer isoform has been called both """"""""""""""""""""""""""""""""b"""""""""""""""""""""""""""""""" and """"""""""""""""""""""""""""""""alpha"""""""""""""""""""""""""""""""", while the shorter isoform has been called both """"""""""""""""""""""""""""""""a"""""""""""""""""""""""""""""""" and """"""""""""""""""""""""""""""""beta"""""""""""""""""""""""""""""""" (PMIDs 1432046, 12091563). [provided by RefSeq, Oct 2014]
Canonical amino-acid sequenceUniProt
511 residues, UniProt reviewed canonical sequence.
>P48547|KCNC1
1 MGQGDESERI VINVGGTRHQ TYRSTLRTLP GTRLAWLAEP DAHSHFDYDP RADEFFFDRH
61 PGVFAHILNY YRTGKLHCPA DVCGPLYEEE LAFWGIDETD VEPCCWMTYR QHRDAEEALD
121 SFGGAPLDNS ADDADADGPG DSGDGEDELE MTKRLALSDS PDGRPGGFWR RWQPRIWALF
181 EDPYSSRYAR YVAFASLFFI LVSITTFCLE THERFNPIVN KTEIENVRNG TQVRYYREAE
241 TEAFLTYIEG VCVVWFTFEF LMRVIFCPNK VEFIKNSLNI IDFVAILPFY LEVGLSGLSS
301 KAAKDVLGFL RVVRFVRILR IFKLTRHFVG LRVLGHTLRA STNEFLLLII FLALGVLIFA
361 TMIYYAERIG AQPNDPSASE HTHFKNIPIG FWWAVVTMTT LGYGDMYPQT WSGMLVGALC
421 ALAGVLTIAM PVPVIVNNFG MYYSLAMAKQ KLPKKKKKHI PRPPQLGSPN YCKSVVNSPH
481 HSTQSDTCPL AQEEILEINR AGRKPLRGMS ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 99 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 99 nTPM
- cerebral cortex: 18 nTPM
- hypothalamus: 8.1 nTPM
- retina: 6.4 nTPM
- basal ganglia: 6.3 nTPM
- amygdala: 5.4 nTPM
Single-cell type
- retinal amacrine cells: 311 nCPM
- brain excitatory neurons: 118 nCPM
- retinal ganglion cells: 108 nCPM
- brain inhibitory neurons: 86 nCPM
- epicardial cells: 82 nCPM
- retinal bipolar cells: 69 nCPM
Immune cell
- basophil: 3.3 nTPM
- neutrophil: 1.3 nTPM
- eosinophil: 0.4 nTPM
- naive B-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- gdT-cell: 0.3 nTPM
Brain region
- cerebral cortex: 163 nTPM
- cerebellum: 149 nTPM
- white matter: 100 nTPM
- thalamus: 87 nTPM
- pons: 83 nTPM
- hypothalamus: 76 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNC1.
Disease | AllUniProt
Conditions KCNC1 is implicated in, by any mechanism.
- Epilepsy, progressive myoclonic 7 (EPM7) MIM:616187
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 535 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Progressive myoclonic epilepsy type 7
- KCNC1-related disorder
- Inborn genetic diseases
- Progressive myoclonic epilepsy
- Developmental and epileptic encephalopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 4.52
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- cellular response to xenobiotic stimulus
- cerebellum development
- corpus callosum development
- globus pallidus development
- optic nerve development
- positive regulation of potassium ion transmembrane transport
- potassium ion transmembrane transport
- potassium ion transport
- protein homooligomerization
- protein tetramerization
- response to amine
- response to auditory stimulus
- response to fibroblast growth factor
- response to light intensity
- response to nerve growth factor
- response to potassium ion
- response to toxic substance
Molecular functions
- delayed rectifier potassium channel activity
- kinesin binding
- transmembrane transporter binding
- voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential
- voltage-gated potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Potassium channel tetramerisation-type BTB domain
- Potassium channel, voltage dependent, Kv
- Potassium channel, voltage dependent, Kv3
- Ion transport domain
- SKP1/BTB/POZ domain superfamily
- Voltage-dependent channel domain superfamily
- Voltage-gated potassium channel
- Ion transport protein
- BTB/POZ domain
- Potassium channel, voltage dependent, Kv3.1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNC1 as an antibody target. Whether an autoantibody or antibody against KCNC1 could matter depends on whether native KCNC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNC1 is annotated at the cell surface, where native KCNC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...